X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
aged (4) 4
female (4) 4
humans (4) 4
middle aged (4) 4
oncology (4) 4
antibodies, monoclonal - administration & dosage (3) 3
index medicus (3) 3
male (3) 3
adult (2) 2
antibodies, monoclonal - adverse effects (2) 2
antibodies, monoclonal, humanized (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
apoptosis (2) 2
cancer (2) 2
chemotherapy (2) 2
combination (2) 2
endothelial growth-factor (2) 2
medicine, research & experimental (2) 2
metastasis (2) 2
neoadjuvant therapy - methods (2) 2
neoplasm staging (2) 2
pharmacology & pharmacy (2) 2
radiology, nuclear medicine & medical imaging (2) 2
targeted therapy (2) 2
treatment outcome (2) 2
tumors (2) 2
2nd-line therapy (1) 1
abridged index medicus (1) 1
adenocarcinoma - therapy (1) 1
adjuvant treatment (1) 1
aged, 80 and over (1) 1
analysis (1) 1
angiogenesis (1) 1
antiangiogenesis (1) 1
antibodies, monoclonal - pharmacokinetics (1) 1
antibody (1) 1
antigens, neoplasm - therapeutic use (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antitumor-activity (1) 1
apoptosis - drug effects (1) 1
article (1) 1
bevacizumab (1) 1
biotin - analogs & derivatives (1) 1
biotin - chemistry (1) 1
biotin - pharmacology (1) 1
bladder-cancer (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - genetics (1) 1
breast neoplasms - pathology (1) 1
cancer therapies (1) 1
cancer-therapy (1) 1
carcinoma (1) 1
carcinoma - drug therapy (1) 1
carcinoma - metabolism (1) 1
carcinoma - pathology (1) 1
carcinoma, transitional cell - drug therapy (1) 1
carcinoma, transitional cell - mortality (1) 1
carcinoma, transitional cell - pathology (1) 1
care and treatment (1) 1
cisplatin (1) 1
clinical medicine (1) 1
clinical trial (1) 1
clinical trials (1) 1
clinical trials as topic (1) 1
cohort studies (1) 1
colon-cancer (1) 1
cytotoxicity (1) 1
death-receptor-5 (1) 1
disease-free survival (1) 1
docetaxel (1) 1
dose-response relationship, drug (1) 1
double-blind method (1) 1
doxorubicin (1) 1
drug therapy (1) 1
efficacy (1) 1
endocrine therapy (1) 1
enzyme-linked immunosorbent assay (1) 1
gamma cameras (1) 1
gastrointestinal neoplasms - therapy (1) 1
genetic aspects (1) 1
glycoproteins - therapeutic use (1) 1
health aspects (1) 1
hematology, oncology and palliative medicine (1) 1
immunotherapy (1) 1
immunotherapytargeted therapy (1) 1
indium radioisotopes (1) 1
internationality (1) 1
kaplan-meier estimate (1) 1
ligand (1) 1
ligands (1) 1
liver neoplasms - secondary (1) 1
lymphoma - drug therapy (1) 1
lymphoma - metabolism (1) 1
lymphoma - pathology (1) 1
lymphomas (1) 1
medical prognosis (1) 1
medicine, general & internal (1) 1
metastases (1) 1
methotrexate (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Petrylak, Daniel and Petrylak, Daniel P and de Wit, Ronald and Chi, Kim Nguyen and Chi, Kim N and Drakaki, Alexandra and Sternberg, Cora N and Nishiyama, Hiroyuki and Castellano, Daniel and Hussain, Syed and Fléchon, Aude and Bamias, Aristotelis and Yu, Evan Y and van der Heijden, Michiel S and Matsubara, Nobuaki and Alekseev, Boris and Necchi, Andrea and Géczi, Lajos and Ou, Yen-Chuan and Coskun, Hasan Senol and Su, Yu-Li and Su, Wen-Pin and Hegemann, Miriam and Percent, Ivor and Percent, Ivor J and Lee, Yun-Gyoo and Lee, Hyo Jin and Lee, Jae-Lyun and Tucci, Marcello and Semenov, Andrey and Laestadius, Fredrik and Peer, Avivit and Tortora, Giampaolo and Safina, Sufia Z and Safina, Sufia and del Muro, Xavier Garcia and Rodriguez-Vida, Alejo and Cicin, Irfan and Harputluoglu, Hakan and Widau, Ryan C and Liepa, Astra M and Walgren, Richard A and Hamid, Oday and Zimmermann, Annamaria H and Bell-McGuinn, Katherine M and Powles, Thomas and Wong, Suet-Lai Shirley and Tan, Thean Hsiang and Hovey, Elizabeth Jane and Clay, Timothy Dudley and Ng, Siobhan Su Wan and Rutten, Annemie and Machiels, Jean-Pascal and Dumez, Herlinde and Cheng, Susanna Yee-Shan and Ferrario, Cristiano and Sengeloev, Lisa and Jensen, Niels Viggo and Thibault, Constance and Laguerre, Brigitte and Joly, Florence and Flechon, Aude and Culine, Stéphane and Becht, Catherine and Niegisch, Günter and Stöckle, Michael and Grimm, Marc-Oliver and Gakis, Georgios and Schultze-Seemann, Wolfgang and Kalofonos, Haralambos and Mavroudis, Dimitrios and Papandreou, Christos and Karavasilis, Vasilis and Révész, Janos and Geczi, Lajos and Rosenbaum, Eli and Leibowitz-Amit, Raya and Kejzman, Daniel and Sarid, David and Scagliotti, Giorgio Vittorio and Bracarda, Sergio and Massari, Francesco and Osawa, Takahiro and Miyajima, Naoto and Shinohara, Nobuo and Fukuta, Fumimasa and Ohyama, Chikara and Obara, Wataru and Yamashita, Shinichi and Tomita, Yoshihiko and Kawai, Koji and Fukasawa, Satoshi and Oyama, Masafumi and Yonese, Junji and Nagata, Masayoshi and Uemura, Motohide and Nishimura, Kazuo and Kawakita, Mutsushi and Tsunemori, Hiroyuki and Hashine, Katsuyoshi and ... and RANGE Study Investigators and RANGE study investigators
The Lancet, ISSN 0140-6736, 11/2017, Volume 390, Issue 10109, pp. 2266 - 2277
Few treatments with a distinct mechanism of action are available for patients with platinum-refractory advanced or metastatic urothelial carcinoma. We assessed... 
BLADDER-CANCER | MEDICINE, GENERAL & INTERNAL | 2ND-LINE THERAPY | TRANSITIONAL-CELL-CARCINOMA | CISPLATIN | DOXORUBICIN | METHOTREXATE | VINBLASTINE | OPEN-LABEL | COMBINATION | ENDOTHELIAL GROWTH-FACTOR | Carcinoma, Transitional Cell - mortality | Prognosis | Humans | Middle Aged | Male | Neoplasm Invasiveness - pathology | Urinary Bladder Neoplasms - pathology | Adult | Female | Urinary Bladder Neoplasms - mortality | Double-Blind Method | Risk Assessment | Docetaxel | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Urinary Bladder Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Carcinoma, Transitional Cell - pathology | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Internationality | Neoadjuvant Therapy - methods | Carcinoma, Transitional Cell - drug therapy | Survival Analysis | Aged | Neoplasm Staging | Antimitotic agents | Care and treatment | Carcinoma | Analysis | Clinical trials | Product development | Metastasis | Antineoplastic agents | Cancer | Cytotoxicity | Oncology | Patients | Cancer therapies | Metastases | Angiogenesis | Chemotherapy | Platinum | Medical prognosis | Ligands | Clinical medicine | Urothelial carcinoma | Vascular endothelial growth factor | Apoptosis
Journal Article
Cancer Biotherapy and Radiopharmaceuticals, ISSN 1084-9785, 02/2010, Volume 25, Issue 1, pp. 13 - 19
Journal Article
Clinical Breast Cancer, ISSN 1526-8209, 2010, Volume 10, Issue 4, pp. 275 - 280
Journal Article
Cancer Biotherapy and Radiopharmaceuticals, ISSN 1084-9785, 2005, Volume 20, Issue 4, pp. 379 - 390
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.